N-(2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)-4-cyanobenzenesulfonamide | 1366131-01-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)-4-cyanobenzenesulfonamide
• 英文别名: 4-Cyano-N-(2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)benzenesulfonamide；4-cyano-N-[2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl]benzenesulfonamide
• CAS: 1366131-01-2
• 化学式: C₁₉H₂₂BN₃O₅S
• 分子量: 415.278
• InChiKey: ASVRZFWKNMVGRK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.06
• 重原子数：
  29
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.37
• 拓扑面积：
  119
• 氢给体数：
  1
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  N-(2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)-4-cyanobenzenesulfonamide 、 6-bromo-1-(4-morpholinophenyl)-1H-benzo[d]imidazol-2-amine 在 1,1'-双(二苯膦基)二茂铁二氯化钯(II)二氯甲烷复合物 碳酸氢钠 作用下， 以 1,4-二氧六环 、 水 为溶剂， 反应 0.17h， 以23.64%的产率得到N-[5-{2-amino-1-[4-(4-morpholinyl)phenyl]-1H-benzimidazol-6-yl}-2-(methyloxy)-3-pyridinyl]-4-cyanobenzenesulfonamide
  参考文献：
  名称：

  [EN] BENZIMIDAZOLE DERIVATIVES AS ANTIVIRAL AGENTS
  [FR] DÉRIVÉS DE BENZIMIDAZOLE EN TANT QU'AGENTS ANTIVIRAUX

  摘要：

  公开号：

  WO2012174312A3
• 作为产物：
  描述：

  3-氨基-5-溴-2-甲氧基吡啶 在 1,1'-双(二苯膦基)二茂铁二氯化钯(II)二氯甲烷复合物 4-二甲氨基吡啶 、 potassium acetate 作用下， 以 1,4-二氧六环 、 吡啶 为溶剂， 反应 21.0h， 生成 N-(2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)-4-cyanobenzenesulfonamide
  参考文献：
  名称：

  [EN] AMINOQUINOLINE DERIVATIVES AS ANTIVIRAL AGENTS
  [FR] DÉRIVÉS D'AMINOQUINOLÉINE COMME AGENTS ANTIVIRAUX

  摘要：

  提供的是式(I)和式(II)的化合物及其药用盐，它们的药物组合物，它们的制备方法，以及它们用于治疗由黄病毒科病毒介导的病毒感染，如丙型肝炎病毒（HCV）。

  公开号：

  WO2012037108A1

文献信息

• Discovery of Pyridopyrimidinones as Potent and Orally Active Dual Inhibitors of PI3K/mTOR
  作者：Tao Yu、Ning Li、Chengde Wu、Amy Guan、Yi Li、Zhengang Peng、Miao He、Jie Li、Zhen Gong、Lei Huang、Bo Gao、Dongling Hao、Jikui Sun、Yan Pan、Liang Shen、Chichung Chan、Xiulian Lu、Hongyu Yuan、Yongguo Li、Jian Li、Shuhui Chen

  DOI：10.1021/acsmedchemlett.8b00002

  日期：2018.3.8

  identification and lead optimization of a series of pyridopyrimidinone derivatives are described as a novel class of efficacious dual PI3K/mTOR inhibitors, resulting in the discovery of 31. Compound 31 exhibited high enzyme activity against PI3K and mTOR, potent suppression of Akt and p70s6k phosphorylation in cell assays, and good pharmacokinetic profile. Furthermore, compound 31 demonstrated in vivo

  一系列嘧啶嘧啶酮衍生物的鉴定和前导优化被描述为一类新型的有效PI3K / mTOR双重抑制剂，导致31的发现。化合物31在细胞分析中显示出对PI3K和mTOR的高酶活性，对Akt和p70s6k磷酸化的有效抑制作用，以及良好的药代动力学特征。此外，化合物31在PC-3M肿瘤异种移植模型中显示出体内功效。
• Synthesis and structure–activity relationships of PI3K/mTOR dual inhibitors from a series of 2-amino-4-methylpyrido[2,3- d ]pyrimidine derivatives
  作者：Fangbin Han、Songwen Lin、Peng Liu、Jing Tao、Chongqin Yi、Heng Xu

  DOI：10.1016/j.bmcl.2014.07.073

  日期：2014.9

  inhibitors provides a promising new approach to the treatment of cancers. In this Letter, we identified structurally novel and potent PI3K/mTOR dual inhibitors from a series of 2-amino-4-methylpyrido[2,3-d]pyrimidine derivatives. Their synthesis and structure–activity relationships are reported.

  PI3K / mTOR双重抑制剂抑制磷酸肌醇3激酶（PI3K）/ AKT /哺乳动物对雷帕霉素（mTOR）信号通路的靶标，为癌症的治疗提供了一种有希望的新方法。在这封信中，我们从一系列的2-氨基-4-甲基吡啶并[2,3- d ]嘧啶衍生物中鉴定了结构新颖且有效的PI3K / mTOR双重抑制剂。报告了它们的合成和结构-活性关系。
• Identification of novel 7-amino-5-methyl-1,6-naphthyridin-2(1H)-one derivatives as potent PI3K/mTOR dual inhibitors
  作者：Songwen Lin、Fangbin Han、Peng Liu、Jing Tao、Xuechao Zhong、Xiujie Liu、Chongqin Yi、Heng Xu

  DOI：10.1016/j.bmcl.2013.12.112

  日期：2014.2

  Inhibition of the phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin ( mTOR) signaling pathway is one of the most intensively studied approaches to cancer therapy. Rational design led to the identification of novel 7-amino-5-methyl-1,6-naphthyridin-2(1H)-one derivatives as potent PI3K/mTOR dual inhibitors. Design, synthesis and structure activity relationship are reported. (C) 2013 Elsevier Ltd. All rights reserved.
• Discovery of a Novel Series of Thienopyrimidine as Highly Potent and Selective PI3K Inhibitors
  作者：Fangbin Han、Songwen Lin、Peng Liu、Xiujie Liu、Jing Tao、Xiaobing Deng、Chongqin Yi、Heng Xu

  DOI：10.1021/ml5005014

  日期：2015.4.9

  Inhibition of the phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway provides a promising new approach for cancer therapy. Through a rational design, a novel series of thienopyrimidine was discovered as highly potent and selective PI3K inhibitors. These thienopyrimidine derivatives were demonstrated to bear nanomolar PI3K alpha inhibitory potency with over 100-fold selectivity against mTOR kinase. The lead compounds 6g and 6k showed good developability profiles in cell-based proliferation and ADME assays. In this communication, their design, synthesis, structure activity relationship, selectivity, and some developability properties are described.
• [EN] AMINOQUINOLINE DERIVATIVES AS ANTIVIRAL AGENTS<br/>[FR] DÉRIVÉS D'AMINOQUINOLÉINE COMME AGENTS ANTIVIRAUX
  申请人：GLAXOSMITHKLINE LLC

  公开号：WO2012037108A1

  公开（公告）日：2012-03-22

  Provided are compounds of Formula (I) and Formula (II) and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the Flaviviridae family of viruses such as hepatitis C virus (HCV).

  提供的是式(I)和式(II)的化合物及其药用盐，它们的药物组合物，它们的制备方法，以及它们用于治疗由黄病毒科病毒介导的病毒感染，如丙型肝炎病毒（HCV）。